Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

NCT07639528 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Resectable Intrahepatic Cholangiocarcinoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Cisplatin
PROCEDURE: Computed Tomography
BIOLOGICAL: Durvalumab
DRUG: Futibatinib
DRUG: Gemcitabine
PROCEDURE: Magnetic Resonance Imaging

Sponsor

Northwestern University

Collaborators

[object Object]